Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multiligand endocytic receptor

被引:50
作者
Neels, JG [1 ]
Horn, IR [1 ]
van den Berg, BMM [1 ]
Pannekoek, H [1 ]
van Zonneveld, AJ [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Biochem K1161, NL-1105 AZ Amsterdam, Netherlands
来源
FIBRINOLYSIS & PROTEOLYSIS | 1998年 / 12卷 / 04期
关键词
D O I
10.1016/S0268-9499(98)80016-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The low density lipoprotein receptor-related protein (LRP) is a large membrane glycoprotein that is a member of the low density lipoprotein (LDL) receptor family of endocytic receptors. In contrast to the restricted ligand specificity of the LDL receptor, LRP can bind and internalize a remarkable spectrum of structurally-unrelated classes of ligands suggesting a role for the receptor in diverse physiological and patho-physiological processes ranging from lipoprotein metabolism, cell growth and cell migration to atherosclerosis and Alzheimer's disease. In this review we will summarize the current insights in the biology of LRP and particularly focus on the recent progress in our understanding of the molecular mechanisms that enable LRP to interact specifically with such a multitude of different ligands.
引用
收藏
页码:219 / 240
页数:22
相关论文
共 273 条
[1]  
ADAMS JC, 1993, J CELL SCI, V104, P1061
[2]  
AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249
[3]   SYNTHETIC PEPTIDES FROM THE CIRCUMSPOROZOITE PROTEINS OF PLASMODIUM-FALCIPARUM AND PLASMODIUM-KNOWLESI RECOGNIZE THE HUMAN HEPATOMA-CELL LINE HEPG2-A16 INVITRO [J].
ALEY, SB ;
BATES, MD ;
TAM, JP ;
HOLLINGDALE, MR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (06) :1915-1922
[4]   STRUCTURE OF EXOTOXIN-A OF PSEUDOMONAS-AERUGINOSA AT 3.0-ANGSTROM RESOLUTION [J].
ALLURED, VS ;
COLLIER, RJ ;
CARROLL, SF ;
MCKAY, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (05) :1320-1324
[5]   RECEPTOR-MEDIATED ENDOCYTOSIS OF PLASMINOGEN ACTIVATORS AND ACTIVATOR/INHIBITOR COMPLEXES [J].
ANDREASEN, PA ;
SOTTRUPJENSEN, L ;
KJOLLER, L ;
NYKJAER, A ;
MOESTRUP, SK ;
PETERSEN, CM ;
GLIEMANN, J .
FEBS LETTERS, 1994, 338 (03) :239-245
[6]   CHARACTERIZATION OF THE ANTIPLASMIN ACTIVITY OF HUMAN THROMBOSPONDIN-1 IN SOLUTION [J].
ANONICK, PK ;
YOO, JK ;
WEBB, DJ ;
GONIAS, SL .
BIOCHEMICAL JOURNAL, 1993, 289 :903-909
[7]   The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor [J].
Argraves, KM ;
Kozarsky, KF ;
Fallon, JT ;
Harpel, PC ;
Strickland, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2170-2181
[8]   THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR MEDIATES THE CELLULAR CATABOLISM OF LIPOPROTEIN-LIPASE AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I COMPLEXES [J].
ARGRAVES, KM ;
BATTEY, FD ;
MACCALMAN, CD ;
MCCRAE, KR ;
GAFVELS, M ;
KOZARSKY, KF ;
CHAPPELL, DA ;
STRAUSS, JF ;
STRICKLAND, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26550-26557
[9]   THE HUMAN ALPHA-2-MACROGLOBULIN RECEPTOR - IDENTIFICATION OF A 420-KD CELL-SURFACE GLYCOPROTEIN SPECIFIC FOR THE ACTIVATED CONFORMATION OF ALPHA-2-MACROGLOBULIN [J].
ASHCOM, JD ;
TILLER, SE ;
DICKERSON, K ;
CRAVENS, JL ;
ARGRAVES, WS ;
STRICKLAND, DK .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1041-1048
[10]  
BAKER MS, 1990, CANCER RES, V50, P4676